Law School

Photo of Dr Hannah Farrimond

Dr Hannah Farrimond

BA, BSc, MSc, Dr

Senior Lecturer (Sociology)

H.R.Farrimond@exeter.ac.uk

5128

01392 725128

Byrne House FF16

Overview

I have two areas of focus at present a) developing a sociology of legal addictions (smoking/vaping, alcohol, pharmaceuticals); also exploring how psychedelics and cannabis are changing the legal/illegal boundaries and b) developing a process model of stigma change, to explain the emergence and evolution of stigmas over time. These two intersect: I have examined the stigma of smoking/vaping, alcohol, sleeping medications, alongside non-drug stigmas such as around Covid-19 and Long Covid. The ultimate aim is to develop a historically and contextually sensitive theory of stigma change which can illuminate if and how stigma can be disrupted.

Current projects include:

  • Developing theories of stigma emergence and change, esp focused on intensity and temporality
  • The lineage, variation and strength of Covid-19 stigma
  • Cultural understandings of legal addictions (e-cigarettes/vaping, alcohol cultures)
  • Identifying pharmaceutical cultures over time 
  • Healthy ageing and addiction
  • Questioning the role of stigma in public health

      Member of: Society for Study of Addiction, International Sociological Association, International Journal of Drug Policy Journal Board.

      Papers full text on ResearchGate, AcademicEdu and the Open Repository at Exeter https://ore.exeter.ac.uk/repository/

      Twitter: @FarrimondH

      Publications (since 2016)

      Farrimond, H. and Michael, M. (in press) How stigma assemblages emerge and mutate: The case of Long Covid stigma, Recalibrating stigma: Sociological perspectives in health and illness, Eds O. Williams, A. Chandler, T. Spratt and G. Thomas, Policy Press (Open Access).

      Farrimond, H., Smith, G., Boyd, K., Fleicher, D. (in press) ‘Don’t take a clipboard and try not to get sat on’: The ethics and practice of data collection as female researchers in a male dominated night-time economy (NTE). Eds K. Hughes, J. Hughes. F* Ups in Social Research: SAGE, London.

      Farrimond, H. (in press) Covid-19 & shame: Political emotions & public health in the UK by Cooper, Dolezal, L., and Rose, A. LSE Book Review.

      Farrimond, H. (2023) Stigma mutation: Tracking lineage, variation and strength in Covid-19 stigma. Sociological Research Online 28 (1): 171-188. https://journals.sagepub.com/doi/10.1177/13607804211031580 (Open Access)

      Estrada Jaramillo, A.L., Michael, M. and Farrimond, H. (2022). Absence, Multiplicity and the Boundaries of Research? Reflections on Online Asynchronous Focus Groups. Qualitative Research.( Open Access) https://journals.sagepub.com/doi/full/10.1177/14687941221110169

      Wilkinson, K., Boyd, K., Pearson, M, Farrimond, H., Lang, I.A., Fleisher, D, Poole, A., Ralph, N., Rappert, B. (2022) Making sense of evidence, in (Ed) Translational Criminology in Policing, 64-68.

      Toller, L. & Farrimond, H. (2021) The unpredictable body, identity and disclosure: Identifying the strategies of chronically ill students at university, Disability Studies Quarterly. https://dsq-sds.org/article/view/7049/5941 (Open Access)

      Farrimond, H. (2021) New pandemics, old politics by De Waal, LSE Book Review

      https://blogs.lse.ac.uk/lsereviewofbooks/2021/05/10/book-review-new-pandemics-old-politics-two-hundred-years-of-war-on-disease-and-its-alternatives-by-alex-de-waal/

      Smith, G. & Farrimond, H. (2019) Active ageing, emotional care and the threat of stigma: Identity management in older adults using sleeping medication long-term, Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 23 (3): 255-272. 

      Farrimond, H. & Abraham, C. (2018) Developing e-cigarette friendly smoking cessation services in England: staff perspectives, Harm Reduction Journal, 15 (1): 38. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076389/ (open access)

      Farrimond, H., Boyd, K. & Fleischer, D. (2018) Reconfiguring the violent encounter? Preloading, security staff and breathalyser use in the night-time economy. International Journal of Drug Policy, 56: 108-115.

      Boyd, K., Farrimond, H., and Ralph, N. (2018) The impact of breathalysers on violence and attitudes in the Night-Time Economy, European Journal of Criminology (in press).

      Farrimond, H. (2017) A typology of vaping: Identifying beliefs, motivations for use, identity and political interest amongst e-cigarette users, International Journal of Drug Policy, 48: 81-90.

      Farrimond, H. (2017) The ethics of research, The Bera/SAGE Handbook of Educational Research, Eds: Dominic Wyse, Emma Smith, Larry E. Suter and Neil Selwyn. SAGE Publications: Thousand Oaks, CA.

      Wilkinson, K., Boyd, K., Pearson, M., Farrimond, H., Lang, I.A., Fleischer, D., Poole. A., Ralph, N., and Rappert, B. (2017) Making sense of evidence: Using research training to promote organisational change. Police Practice and Research.

      Farrimond. H. (2016) E-cigarette regulation and policy: UK vapers' perspectives, Addiction, 111 (6): 1077-1083.

      Carrieri, D., Farrimond, H., Kelly, S.E. and Turnpenny, P.D. (2016) Families dealing with the uncertainty of genetic disorders: the case of Neurofibromatosis Type 1, Sociology of Health and Illness, 38(5):753-67

      Grants

      ESRC IAA Project Co-creation Award, '#RU2Drunk? Evaluation of the roll-out of a breathalyser initiative to reduce alcohol-related violence in the South West, July-Dec '16, PI Hannah Farrimond and Katharine  Boyd, Collaborators Devon and Cornwall/Dorset Police Strategic Alliance, £19, 787.

      Reframing stop smoking services in response to e-cigarette use: An exploratory stakeholder study', Cancer Research UK, PI Dr Hannah Farrimond, Collaborator Prof. Charles Abraham, 18 months, start March 2016, £43,000.

      Police Knowledge Fund ExPERT (Exeter Policing, Evidence and Research Translation) Project, Start date Sept 2015, 18 months, Co-I, £249,450.

      Q-Step Centre for Quantitative Methods at the University of Exeter (£1.2 million), start 2014 for five years, Academic Lead for SPA department

      Back to top

      Research

      Covid-19 and stigma: Change over time

      Extending my previous thinking about stigma, I have been tracking Covid-19 stigma over time. Some trends can be discerned. For example, familiar from previous epidemics, we can see the identification and projection of difference onto ‘Others’. Covid stigma is created, for example, through the pejorative labelling of the virus (e.g. the Chinese virus), projecting ‘disgusting’ or conspiracy origin stories onto whole ‘carrier’ groups, and blaming those returning home as ‘infecting from outside’. Counter-stigmatizing trends are also visible. Public figures, such as the actor Tom Hanks, followed by politicians, sportspeople and the royal family, have disclosed their corona status. In doing so, high status groups in the West may have converted ‘testing positive’ into shared rather than shamed behaviour. However, international divergence is already observed. As moral discourses concerning risk, controllability and blame intensify or die down, Covid-19 stigma changes over time. In particular new form are emerging, such as the stigmatisation of Long Covid. 

      Other

      My non-Covid-19 research continues to focus on a) legal addictions and their social meanings, especially alcohol, tobacco/vaping and pharmaceuticals and b) stigma, particularly how it transforms/changes over time, and the stigma of addictions including the role of public health in challenging or perpetuating stigma. I have developed a theory of stigma mutation which can be used to understand emergent stigma through three dimensions a) lineage b) variation and c) strength. I am currently working through a series of case-studies of stigma (on alcohol, smoking/vaping, psychedelics, as well as Covid/Long Covid) to further refine the theory, particularly in relation to existence of stigma assemblages and their temporality.

      Research group links

      Back to top

      Supervision

      Supervision

      I am interested in supervising PhD's in the following areas:

      • Social practices of legal drug use esp smoking/vaping, alcohol and pharmaceuticals
      • Addiction in relation to legal and illegal drug use
      • Stigma theory
      • Medicalization/pharmaceuticalization
      • Qualitative/mixed methods/Q-methodology

      Completed PhDs

      2016-2022 Rosanna Mead, Meaningful music in Dementia Care: Anchoring within Transient Situations.

      2016-2020 Georgia Smith, 1 + 3 ESRC studentship, 'The Long Night: Framing Sleeping Medication Use in Later Life'

      2015-2018. Hazel O'Brien, 'Being Mormon in Ireland: An ethnographic study of two Mormon communities in Ireland' 

      2008-2011 Daniele Carrieri, 'Neurofibromatosis Type 1 (NF1): Patients and Families Experiences and Health Care System Management of a Complex Genetic Syndrome’

      Examined PhDs

      2020 (external) Daniel Erku, University of Queensland, Australia 'Exploring the role of health professionals in communicating health messages about nicotine vaping products to smokers: A multiple methods approach'

      2015 (internal) David Wyatt

      2013 (internal) Louise Bezuidenhout

      2012 (internal) Sally Wasmuth

      Current PhDs

      Louise Toller, 1 + 3 ESRC studentship, Social constructions of a liminal condition (M.E.) in young people. 

      Courtney Buckler 1 + 3 ESRC studentship. Evidence-based medicine as an ideological tool in psychiatric discourse.

      Ana Lucia Estrada Jamarillo, The logics of care in congenital syphilis in Western Colombia, Colombian Government/UK collaborative funding

      Margaret Chirgwin. Why are UK doctors leaving medical practice prematurely (i.e. before retirement age)?

      Back to top

      Publications

      Copyright Notice: Any articles made available for download are for personal use only. Any other use requires prior permission of the author and the copyright holder.

      | 2022 | 2021 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2003 |

      2022

      2021

      2019

      2018

      2016

      • Leppard M, Ingledew DK, Farrimond H. (2016) Book Reviews, Journal of Health Psychology, volume 8, no. 2, pages 277-282, DOI:10.1177/1359105303008002675.
      • Farrimond HR. (2016) The ethics of research, THE BERA/SAGE HANDBOOK OF EDUCATIONAL RESEARCH, SAGE.
      • Farrimond HR. (2016) E-cigarette regulation and policy: UK vapers’ perspectives, Addiction, volume 111 (6), pages 1077-1083.
      • Carrieri D, Farrimond HR, Kelly SE, Turnpenny PD. (2016) Families dealing with the uncertainty of genetic disorders: the case of Neurofibromatosis Type 1, Sociology of Health and Illness, volume 38, no. 5, pages 753-767, DOI:10.1111/1467-9566.12401.

      2015

      2014

      • Farrimond HR. (2014) E-cigarettes and vaping: Public health solution or risk?, BSA Medical Sociology Group Annual Conference 2014, Aston University, Birmingham, Uk, 10th - 12th Sep 2014.

      2013

      2012

      • Farrimond HR. (2012) What do the public think of new non-invasive pre-natal genetic tests?, ESRC Genomics Network Conference 2012, Genomics in Society: Facts, Fictions and Cultures, British Library, London, 24th - 25th Apr 2012.
      • Farrimond HR. (2012) Understandings of Type 2 diabetes in 'at risk' families, ESRC Genomics Network Conference 2012, Genomics in Society: Facts, Fictions and Cultures, British Library, London, 24th - 25th Apr 2012.
      • Farrimond HR. (2012) Understandings of Type 2 diabetes in 'at risk' families, , British Psychological Society, Health Psychology Division Annual Conference, Liverpool, 5th - 7th Sep 2012.
      • Kelly SE, Farrimond HR. (2012) Non-invasive prenatal genetic testing: a study of public attitudes, Public Health Genomics, volume 15, no. 2, pages 73-81, DOI:10.1159/000331254. [PDF]
      • Saukko PS, Farrimond HR, Qureshi N, Evans PE. (2012) Beyond beliefs: Risk assessment technologies shaping patient experiences of heart disease prevention, Sociology of Health and Illness, volume 34, no. 4, pages 560-575, DOI:10.1111/j.1467-9566.2011.01406.x.
      • Farrimond HR. (2012) Beyond the caveman: Rethinking masculinity in relation to men’s help-seeking, Health: an interdisciplinary journal for the social study of health, illness and medicine, volume 16, no. 2, pages 208-225, DOI:10.1177/1363459311403943.

      2011

      • Farrimond HR, Kelly SE. (2011) ‘It made me think’: Using Q-methodology to investigate public viewpoints of emerging pre-natal genetic technologies, 7th International Mixed Methods Conference, University Of Leeds, 29th - 30th Jun 2011.
      • Farrimond HR. (2011) Teaching ethics relating to research with human participants, Professional and Research Ethics, Centre For Bioscience, University Of Leicester, 5th - 5th May 2011.
      • Farrimond H, Kelly SE. (2011) Public viewpoints on novel non-invasive technologies for prenatal genetic diagnosis, Public Understanding of Science, DOI:10.1177/0963662511424359.

      2010

      • Carrieri D, Farrimond HR, Kelly SE, Turnpenny P. (2010) Fragmented biosociality: Familial meanings of Neurofibromatosis Type 1, British Society for Human Genetics, University Of Warwick, Uk, 4th - 6th Sep 2010.
      • Farrimond H. (2010) Conceptualizing non-invasiveness in new prenatal testing technologies, Concepts of Health and Illness, Bristol, 2nd - 4th Sep 2010.
      • Farrimond HR, Kelly SE. (2010) Interrogating the concept of non-invasiveness in new reproductive testing technologies, AMH (Association of Medical Humanities) Annual Conference, Truro, Uk, 5th - 7th Jul 2010.
      • Kelly SE, Farrimond HR. (2010) Non-invasive prenatal genetic testing: A study of public attitudes, ISPD (International Society for Prenatal Diagnosis) 15th International Conference, Amsterdam, The Netherlands, 11th - 14th Jul 2010.
      • Farrimond HR, Kelly SE. (2010) New non-invasive prenatal genetic technologies: Public understandings and concerns, EMPAG (European Meeting on Psychosocial Aspects of Genetics), Gothenburg, Sweden, 12th - 15th Jun 2010.
      • Farrimond HR, Saukko PM, Evans PH, Qureshi N. (2010) Making sense of being at ‘high risk’ of coronary heart disease, Psychology and Health, volume 25, no. 3, pages 289-304, DOI:10.1080/08870440802499382.
      • Farrimond HR, Joffe H, Stenner P. (2010) A Q-methodological study of 'smoking identities', Psychology and Health, volume 25, no. 8, pages 979-998, DOI:10.1080/08870440903151080.

      2009

      • Farrimond H. (2009) A Sheep in Sheep’s Clothing: Mixing it up, Dolly-Style, Metascience, volume 18, no. 1, pages 99-102, DOI:10.1007/s11016-009-9257-y.
      • Qureshi N, Armstrong S, Saukko P, Sach T, Middlemass J, Evans PH, Kai J, Farrimond H, Humphries SE. (2009) Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol, BMC Health Services Research, volume 9.
      • Farrimond HR, Kelly SE. (2009) Is easier always better? Public attitudes towards non-invasive prenatal testing, EGN Genomics Network Annual Conference, Cardiff, 7th - 9th Oct 2009.

      2008

      • Saukko P, Farrimond HR, Evans P, Qureshi N. (2008) Clinicans' views on using family history in primary prevention of heart disease: A qualitative focus groups study, Society of Academic Primary Care (SAPC) 37th Annual Meeting, Galway, Ireland, 9th - 11th Jul 2008.
      • Saukko P, Farrimond HR, Qureshi N, Evans P. (2008) Managing behavioural and biochemical notions of heart disease: Patients' and clinicians' accounts of statin use in primary prevention, Society of Academic Primary Care (SAPC) 37th Annual Meeting, Galway, Ireland, 9th - 11th Jul 2008.
      • Farrimond HR. (2008) Commentary on genetic variation in health and illness, Human Nature and Variation workshop, Exeter, Uk.
      • Farrimond HR. (2008) Visual representations of smokers, From Ethnomethodology to Cyborg Sociology: Discussing qualitative methods, Exeter, Uk.
      • Farrimond HR, Saukko PM, Qureshi N, Evans PH. (2008) Risk, family history and live-course: Patient perceptions of being at 'high risk' of heart disease, ESRC Genomics Network Conference 'Genomics and Society: Reinventing Life?', London, Uk, 27th - 28th Oct 2008.
      • Farrimond HR. (2008) Mixing it up, Dolly-Style, Metascience, volume 18, no. 1.
      • Farrimond HR, Saukko PM, Qureshi N, Evans PH. (2008) Lifestyle, life-stage and social context: Patient perceptions of being 'high risk' of heart disease, British Psychological Society Health Division Annual Conference, Bath, 9th - 12th Sep 2008, Psychology and Health, volume 23, no. Supplement 1.

      2007

      • Farrimond HR, Saukko P, Evans P, Qureshi N. (2007) The use of family history in risk assessment and primary prevention of heart disease, Governing Genomics, Exeter, Uk, 25th - 27th Jan 2007.
      • Farrimond HR, Saukko P, Evans P, Qureshi N. (2007) Adding 'family history' to coronary heart disease risk assessments: A qualitative study, Genomics in Society, 1st International Conference, London, Uk, 26th - 27th Oct 2007.

      2006

      2003

      • Wardle J, Jarvis MJ, Steggles N, Sutton S, Williamson S, Farrimond H, Cartwright M, Simon AE. (2003) Socioeconomic disparities in cancer-risk behaviours in adolescence: Baseline results from the Health and Behaviour in Teenagers Study (HABITS), Preventive Medicine, no. 36, pages 721-730.
      • Farrimond HR. (2003) Book review of Health: The foundations of achievement, Journal of Health Psychology, volume 2, no. 8, pages 280-282.

      Back to top

      External impact and engagement

      ESRC IAA Project Co-creation Award, '#RU2Drunk? Evaluation of the roll-out of a breathalyser initiative to reduce alcohol-related violence in the South West, July-Dec '16, PI Hannah Farrimond and Katharine  Boyd, Collaborators Devon and Cornwall/Dorset Police Strategic Alliance, £19, 787.

      Back to top

      Teaching

      Modules taught

      • ANT3085 - Health, Illness and Bodies in Contemporary Society Part 1: Medicine and Social Control
      • ANT3086 - Addiction
      • SOC2037 - Pharmaceutical Cultures
      • SOC3085 - Health, Illness and Bodies in Contemporary Society Part 1: Medicine and Social Control
      • SOC3086 - Addiction

      Back to top

      Biography

      My PhD in Psychology on 'Smoking Identities in Higher and Lower Socio-economic Groups in the UK' was awarded in 2007 by UCL. I then joined the University of Exeter as a research associate at EGENIS (Exeter Centre for the Study of Life Sciences), moving to a lecturer (2016), then senior lecturer post (2018). 

      Back to top

       Edit profile